Exact Mass: 883.6537

PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))

C52H86NO8P (883.6091)

PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of adrenic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The adrenic acid moiety is derived from animal fats, while the docosapentaenoic acid moiety is derived from animal fats and brain. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))

C52H86NO8P (883.6091)

PC(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of adrenic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The adrenic acid moiety is derived from animal fats, while the docosapentaenoic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))

C52H86NO8P (883.6091)

PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of adrenic acid at the C-2 position. The docosapentaenoic acid moiety is derived from animal fats and brain, while the adrenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))

C52H86NO8P (883.6091)

PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)), in particular, consists of one chain of docosapentaenoic acid at the C-1 position and one chain of adrenic acid at the C-2 position. The docosapentaenoic acid moiety is derived from fish oils, while the adrenic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(22:1(13Z)/24:1(15Z))

C51H98NO8P (883.703)

PE(22:1(13Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/24:1(15Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:1(13Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/24:1(15Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:2(13Z,16Z)/24:0)

C51H98NO8P (883.703)

PE(22:2(13Z,16Z)/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/24:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:0/22:2(13Z,16Z))

C51H98NO8P (883.703)

PE(24:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/22:2(13Z,16Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:1(15Z)/22:1(13Z))

C51H98NO8P (883.703)

PE(24:1(15Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/22:1(13Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of erucic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE-NMe2(20:1(11Z)/24:1(15Z))

C51H98NO8P (883.703)

PE-NMe2(20:1(11Z)/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/24:1(15Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:2(11Z,14Z)/24:0)

C51H98NO8P (883.703)

PE-NMe2(20:2(11Z,14Z)/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:2(11Z,14Z)/24:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:0/22:2(13Z,16Z))

C51H98NO8P (883.703)

PE-NMe2(22:0/22:2(13Z,16Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/22:2(13Z,16Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/22:1(13Z))

C51H98NO8P (883.703)

PE-NMe2(22:1(13Z)/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/22:1(13Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:2(13Z,16Z)/22:0)

C51H98NO8P (883.703)

PE-NMe2(22:2(13Z,16Z)/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:2(13Z,16Z)/22:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:0/20:2(11Z,14Z))

C51H98NO8P (883.703)

PE-NMe2(24:0/20:2(11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:0/20:2(11Z,14Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:1(15Z)/20:1(11Z))

C51H98NO8P (883.703)

PE-NMe2(24:1(15Z)/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/20:1(11Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE(24:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C49H90NO10P (883.6302)

PE(24:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(24:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of Leukotriene B4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/24:0)

C49H90NO10P (883.6302)

PE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/24:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/24:0), in particular, consists of one chain of one Leukotriene B4 at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(24:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C49H90NO10P (883.6302)

PE(24:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(24:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/24:0)

C49H90NO10P (883.6302)

PE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/24:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/24:0), in particular, consists of one chain of one 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(24:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C49H90NO10P (883.6302)

PE(24:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(24:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/24:0)

C49H90NO10P (883.6302)

PE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/24:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/24:0), in particular, consists of one chain of one 5,6-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(24:1(15Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

C49H90NO10P (883.6302)

PE(24:1(15Z)/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(24:1(15Z)/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(20:3(8Z,11Z,14Z)-2OH(5,6)/24:1(15Z))

C49H90NO10P (883.6302)

PE(20:3(8Z,11Z,14Z)-2OH(5,6)/24:1(15Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:3(8Z,11Z,14Z)-2OH(5,6)/24:1(15Z)), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PC(22:0/20:3(6,8,11)-OH(5))

C50H94NO9P (883.6666)

PC(22:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one docosanoyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(20:3(6,8,11)-OH(5)/22:0)

C50H94NO9P (883.6666)

PC(20:3(6,8,11)-OH(5)/22:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(20:3(6,8,11)-OH(5)/22:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of docosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(22:3(10Z,13Z,16Z)/18:1(12Z)-2OH(9,10))

C49H90NO10P (883.6302)

PC(22:3(10Z,13Z,16Z)/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(22:3(10Z,13Z,16Z)/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(12Z)-2OH(9,10)/22:3(10Z,13Z,16Z))

C49H90NO10P (883.6302)

PC(18:1(12Z)-2OH(9,10)/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-2OH(9,10)/22:3(10Z,13Z,16Z)), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:0/18:2(10E,12Z)+=O(9))

C50H94NO9P (883.6666)

PC(24:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:2(10E,12Z)+=O(9)/24:0)

C50H94NO9P (883.6666)

PC(18:2(10E,12Z)+=O(9)/24:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:2(10E,12Z)+=O(9)/24:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:0/18:2(9Z,11E)+=O(13))

C50H94NO9P (883.6666)

PC(24:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:2(9Z,11E)+=O(13)/24:0)

C50H94NO9P (883.6666)

PC(18:2(9Z,11E)+=O(13)/24:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:2(9Z,11E)+=O(13)/24:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:0/18:3(10,12,15)-OH(9))

C50H94NO9P (883.6666)

PC(24:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:3(10,12,15)-OH(9)/24:0)

C50H94NO9P (883.6666)

PC(18:3(10,12,15)-OH(9)/24:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:3(10,12,15)-OH(9)/24:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:0/18:3(9,11,15)-OH(13))

C50H94NO9P (883.6666)

PC(24:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:3(9,11,15)-OH(13)/24:0)

C50H94NO9P (883.6666)

PC(18:3(9,11,15)-OH(13)/24:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:3(9,11,15)-OH(13)/24:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:1(12Z)-O(9S,10R))

C50H94NO9P (883.6666)

PC(24:1(15Z)/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(12Z)-O(9S,10R)/24:1(15Z))

C50H94NO9P (883.6666)

PC(18:1(12Z)-O(9S,10R)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-O(9S,10R)/24:1(15Z)), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(24:1(15Z)/18:1(9Z)-O(12,13))

C50H94NO9P (883.6666)

PC(24:1(15Z)/18:1(9Z)-O(12,13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(24:1(15Z)/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 15Z-tetracosenoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(9Z)-O(12,13)/24:1(15Z))

C50H94NO9P (883.6666)

PC(18:1(9Z)-O(12,13)/24:1(15Z)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(9Z)-O(12,13)/24:1(15Z)), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 15Z-tetracosenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Lecithin

C52H86NO8P (883.6091)

PE(46:2)

C51H98NO8P (883.703)

PC(21:0/22:2(13Z,16Z))

C51H98NO8P (883.703)

PC(22:2(13Z,16Z)/21:0)

C51H98NO8P (883.703)

PC 43:2

C51H98NO8P (883.703)

PC(24:0/18:2(10E,12Z)+=O(9))

C50H94NO9P (883.6666)

PC(18:2(10E,12Z)+=O(9)/24:0)

C50H94NO9P (883.6666)

PC(24:0/18:2(9Z,11E)+=O(13))

C50H94NO9P (883.6666)

PC(18:2(9Z,11E)+=O(13)/24:0)

C50H94NO9P (883.6666)

[(2R)-3-docosanoyloxy-2-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

[(2R)-2-docosanoyloxy-3-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

[(2R)-2-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

[(2R)-3-[(10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoyl]oxy-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

[(2R)-2-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

[(2R)-3-[(9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoyl]oxy-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H94NO9P (883.6666)

PC(24:1(15Z)/18:1(12Z)-O(9S,10R))

C50H94NO9P (883.6666)

PC(18:1(12Z)-O(9S,10R)/24:1(15Z))

C50H94NO9P (883.6666)

PC(24:1(15Z)/18:1(9Z)-O(12,13))

C50H94NO9P (883.6666)

PC(18:1(9Z)-O(12,13)/24:1(15Z))

C50H94NO9P (883.6666)

PE(24:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C49H90NO10P (883.6302)

PE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/24:0)

C49H90NO10P (883.6302)

PE(24:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C49H90NO10P (883.6302)

PE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/24:0)

C49H90NO10P (883.6302)

PE(24:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C49H90NO10P (883.6302)

PE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/24:0)

C49H90NO10P (883.6302)

PE(24:1(15Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

C49H90NO10P (883.6302)

PE(20:3(8Z,11Z,14Z)-2OH(5,6)/24:1(15Z))

C49H90NO10P (883.6302)

PC(22:3(10Z,13Z,16Z)/18:1(12Z)-2OH(9,10))

C49H90NO10P (883.6302)

PC(18:1(12Z)-2OH(9,10)/22:3(10Z,13Z,16Z))

C49H90NO10P (883.6302)

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

HexCer 8:1;2O/40:6

C54H93NO8 (883.6901)

HexCer 8:0;2O/40:7

C54H93NO8 (883.6901)

HexCer 24:3;2O/24:4

C54H93NO8 (883.6901)

HexCer 14:1;2O/34:6

C54H93NO8 (883.6901)

HexCer 26:3;2O/22:4

C54H93NO8 (883.6901)

HexCer 16:3;2O/32:4

C54H93NO8 (883.6901)

HexCer 16:0;2O/32:7

C54H93NO8 (883.6901)

HexCer 18:2;2O/30:5

C54H93NO8 (883.6901)

HexCer 22:0;2O/26:7

C54H93NO8 (883.6901)

HexCer 14:2;2O/34:5

C54H93NO8 (883.6901)

HexCer 32:3;2O/16:4

C54H93NO8 (883.6901)

HexCer 16:1;2O/32:6

C54H93NO8 (883.6901)

HexCer 20:0;2O/28:7

C54H93NO8 (883.6901)

HexCer 28:3;2O/20:4

C54H93NO8 (883.6901)

HexCer 12:0;2O/36:7

C54H93NO8 (883.6901)

HexCer 10:1;2O/38:6

C54H93NO8 (883.6901)

HexCer 20:1;2O/28:6

C54H93NO8 (883.6901)

HexCer 18:0;2O/30:7

C54H93NO8 (883.6901)

HexCer 30:2;2O/18:5

C54H93NO8 (883.6901)

HexCer 24:1;2O/24:6

C54H93NO8 (883.6901)

HexCer 10:0;2O/38:7

C54H93NO8 (883.6901)

HexCer 18:3;2O/30:4

C54H93NO8 (883.6901)

HexCer 24:2;2O/24:5

C54H93NO8 (883.6901)

HexCer 22:3;2O/26:4

C54H93NO8 (883.6901)

HexCer 12:1;2O/36:6

C54H93NO8 (883.6901)

HexCer 22:2;2O/26:5

C54H93NO8 (883.6901)

HexCer 20:3;2O/28:4

C54H93NO8 (883.6901)

HexCer 14:3;2O/34:4

C54H93NO8 (883.6901)

HexCer 14:0;2O/34:7

C54H93NO8 (883.6901)

HexCer 26:2;2O/22:5

C54H93NO8 (883.6901)

HexCer 18:1;2O/30:6

C54H93NO8 (883.6901)

HexCer 20:2;2O/28:5

C54H93NO8 (883.6901)

HexCer 12:2;2O/36:5

C54H93NO8 (883.6901)

HexCer 22:1;2O/26:6

C54H93NO8 (883.6901)

HexCer 26:1;2O/22:6

C54H93NO8 (883.6901)

HexCer 28:2;2O/20:5

C54H93NO8 (883.6901)

HexCer 16:2;2O/32:5

C54H93NO8 (883.6901)

HexCer 30:3;2O/18:4

C54H93NO8 (883.6901)

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C53H90NO7P (883.6455)

2-[2-[(18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-18,21,24,27,30,33-hexaenoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

Lnaps 21:0/N-22:3

C49H90NO10P (883.6302)

Lnape 19:2/N-27:0

C51H98NO8P (883.703)

Lnaps 21:1/N-22:2

C49H90NO10P (883.6302)

Lnape 25:0/N-21:2

C51H98NO8P (883.703)

Lnaps 17:2/N-26:1

C49H90NO10P (883.6302)

Lnaps 26:1/N-17:2

C49H90NO10P (883.6302)

Lnaps 26:3/N-17:0

C49H90NO10P (883.6302)

Lnaps 22:3/N-21:0

C49H90NO10P (883.6302)

Lnaps 26:2/N-17:1

C49H90NO10P (883.6302)

Lnape 26:7/N-21:2

C52H86NO8P (883.6091)

Lnaps 25:0/N-18:3

C49H90NO10P (883.6302)

Lnape 21:2/N-26:7

C52H86NO8P (883.6091)

Lnaps 19:1/N-24:2

C49H90NO10P (883.6302)

Lnape 21:2/N-25:0

C51H98NO8P (883.703)

Lnaps 20:3/N-23:0

C49H90NO10P (883.6302)

Lnaps 24:2/N-19:1

C49H90NO10P (883.6302)

Lnape 22:0/N-24:2

C51H98NO8P (883.703)

Lnape 24:1/N-22:1

C51H98NO8P (883.703)

Lnape 26:0/N-20:2

C51H98NO8P (883.703)

Lnaps 21:2/N-22:1

C49H90NO10P (883.6302)

Lnaps 17:0/N-26:3

C49H90NO10P (883.6302)

Lnape 26:1/N-20:1

C51H98NO8P (883.703)

Lnape 22:2/N-24:0

C51H98NO8P (883.703)

Lnape 24:2/N-22:0

C51H98NO8P (883.703)

Lnaps 24:3/N-19:0

C49H90NO10P (883.6302)

Lnaps 22:2/N-21:1

C49H90NO10P (883.6302)

Lnape 20:1/N-26:1

C51H98NO8P (883.703)

Lnape 22:1/N-24:1

C51H98NO8P (883.703)

Lnaps 24:1/N-19:2

C49H90NO10P (883.6302)

Lnape 20:2/N-26:0

C51H98NO8P (883.703)

Lnape 20:0/N-26:2

C51H98NO8P (883.703)

Lnape 27:0/N-19:2

C51H98NO8P (883.703)

Lnaps 16:3/N-27:0

C49H90NO10P (883.6302)

Lnape 26:2/N-20:0

C51H98NO8P (883.703)

Lnape 24:0/N-22:2

C51H98NO8P (883.703)

Lnaps 22:1/N-21:2

C49H90NO10P (883.6302)

Lnaps 19:2/N-24:1

C49H90NO10P (883.6302)

Lnaps 27:0/N-16:3

C49H90NO10P (883.6302)

Lnaps 23:0/N-20:3

C49H90NO10P (883.6302)

Lnaps 18:3/N-25:0

C49H90NO10P (883.6302)

Lnaps 17:1/N-26:2

C49H90NO10P (883.6302)

Lnaps 19:0/N-24:3

C49H90NO10P (883.6302)

2-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-hexadecanoyloxy-2-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(Z)-hexacos-15-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-2-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(Z)-tetradec-9-enoyl]oxy-2-[(15Z,18Z,21Z,24Z,27Z)-triaconta-15,18,21,24,27-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-dodecanoyloxy-2-[(14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-14,17,20,23,26,29-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-decanoyloxy-2-[(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-16,19,22,25,28,31-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-tetradecanoyloxy-2-[(12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(Z)-hexadec-9-enoyl]oxy-2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-docos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(Z)-icos-11-enoyl]oxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-docosanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-icosanoyloxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[2,3-bis[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy]propoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

2-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C54H93NO8 (883.6901)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoxy]propan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propan-2-yl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoxy]propan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]propan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propan-2-yl] (11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C53H90NO7P (883.6455)

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-tetracosoxypropoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C53H90NO7P (883.6455)

2-amino-3-[[2-[(Z)-hexacos-15-enoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[2-icosanoyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-[(Z)-docos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-[(Z)-tetracos-13-enoxy]propoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C53H90NO7P (883.6455)

2-amino-3-[[3-hexacosoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[3-[(Z)-hexacos-15-enoxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[3-icosoxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-tetracosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-docosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-docosanoyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

2-amino-3-[[2-hexacosanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C50H94NO9P (883.6666)

[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C53H90NO7P (883.6455)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] nonacosanoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoate

C52H86NO8P (883.6091)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] octacosanoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (23Z,26Z)-tetratriaconta-23,26-dienoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (25Z,28Z)-hexatriaconta-25,28-dienoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (Z)-triacont-19-enoate

C51H98NO8P (883.703)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] triacontanoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (19Z,22Z)-triaconta-19,22-dienoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropan-2-yl] (9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-dotriacont-21-enoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (21Z,24Z)-dotriaconta-21,24-dienoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-octacos-17-enoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]propan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C53H90NO7P (883.6455)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoate

C52H86NO8P (883.6091)

[3-nonanoyloxy-2-[(23Z,26Z)-tetratriaconta-23,26-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (27Z,30Z)-octatriaconta-27,30-dienoate

C51H98NO8P (883.703)

[2-[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C51H98NO8P (883.703)

2-amino-3-[[3-[(Z)-docos-13-enoyl]oxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-hexacos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

2-amino-3-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-pentacosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-henicos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

2-amino-3-[hydroxy-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

2-amino-3-[hydroxy-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] tetracosanoate

C51H98NO8P (883.703)

2-amino-3-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] pentacosanoate

C51H98NO8P (883.703)

2-amino-3-[[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-henicosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C51H98NO8P (883.703)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] heptacosanoate

C51H98NO8P (883.703)

2-amino-3-[[3-[(Z)-heptadec-9-enoyl]oxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (Z)-hexacos-15-enoate

C51H98NO8P (883.703)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C51H98NO8P (883.703)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] hexacosanoate

C51H98NO8P (883.703)

[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-2-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(Z)-triacont-19-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-dodecanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-decanoyloxy-2-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(Z)-tetradec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(19Z,22Z)-triaconta-19,22-dienoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(Z)-octacos-17-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(21Z,24Z)-dotriaconta-21,24-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-docosanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-heptacosanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-[(Z)-nonadec-9-enoyl]oxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

2-amino-3-[[3-heptacosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[3-nonadecanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-heptadecanoyloxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-henicos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C51H98NO8P (883.703)

[(2R)-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[(2R)-2-[(6E,9E)-octadeca-6,9-dienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2S)-2-heptadecanoyloxy-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropyl] hexacosanoate

C51H98NO8P (883.703)

[(2R)-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

4-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-docos-13-enoyl]oxypropyl] (E)-tetracos-15-enoate

C51H98NO8P (883.703)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C51H98NO8P (883.703)

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hexacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5E,8E)-icosa-5,8-dienoyl]oxypropan-2-yl] hexacosanoate

C51H98NO8P (883.703)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C51H98NO8P (883.703)

[(2R)-3-[(2E,4E)-octadeca-2,4-dienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

(2R)-2-amino-3-[hydroxy-[(2S)-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-3-pentacosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(13E,16E)-docosa-13,16-dienoyl]oxypropyl] tetracosanoate

C51H98NO8P (883.703)

[(2R)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[(2R)-3-[(6E,9E)-octadeca-6,9-dienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

4-[3-[(5E,8E,11E,14E,17E,20E,23E)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

[(2R)-2-[(2E,4E)-octadeca-2,4-dienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropan-2-yl] hexacosanoate

C51H98NO8P (883.703)

(2S)-2-amino-3-[[(2S)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-[(E)-hexacos-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-2-[(9E,12E)-octadeca-9,12-dienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2S)-2-[(E)-heptadec-9-enoyl]oxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

(2S)-2-amino-3-[[(2S)-3-[(E)-heptadec-9-enoyl]oxy-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

4-[2-[(5E,8E,11E,14E,17E,20E,23E)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

4-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

(2R)-2-amino-3-[hydroxy-[(2S)-2-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-3-pentacosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

4-[2,3-bis[[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

4-[2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-2-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-hexacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxy-3-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-2-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

[(2R)-3-[(9E,12E)-octadeca-9,12-dienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] (E)-hexacos-5-enoate

C51H98NO8P (883.703)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] (E)-hexacos-5-enoate

C51H98NO8P (883.703)

(2S)-2-amino-3-[hydroxy-[(2S)-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxy-2-pentacosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13E,16E)-docosa-13,16-dienoyl]oxypropan-2-yl] tetracosanoate

C51H98NO8P (883.703)

[(2R)-2-[(9E,11E)-octadeca-9,11-dienoyl]oxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-[(7E,10E,13E,16E)-docosa-7,10,13,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C52H86NO8P (883.6091)

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-tricosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

4-[2-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-[(7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

(2S)-2-amino-3-[hydroxy-[(2S)-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxy-2-pentacosanoyloxypropoxy]phosphoryl]oxypropanoic acid

C49H90NO10P (883.6302)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-[(9E,11E)-octadeca-9,11-dienoyl]oxy-2-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-icosanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C51H98NO8P (883.703)

4-[2-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

[(2R)-3-heptadecanoyloxy-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H98NO8P (883.703)

4-[3-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C56H85NO7 (883.6326)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-docos-13-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C51H98NO8P (883.703)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropyl] hexacosanoate

C51H98NO8P (883.703)

2-[[(4E,8E)-2-[[(15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-15,18,21,24,27,30,33-heptaenoyl]amino]-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoyl]amino]tetradeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-14,17,20,23,26,29-hexaenoyl]amino]-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]tetracosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]icosa-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(E)-3-hydroxy-2-[[(16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-16,19,22,25,28,31,34,37-octaenoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]amino]icosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoyl]amino]-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(E)-3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoyl]amino]tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(4E,8E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxydocosa-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyhexacosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoyl]amino]-3-hydroxydodecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(E)-3-hydroxy-2-[[(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-14,17,20,23,26,29,32,35-octaenoyl]amino]dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(E)-2-[[(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoyl]amino]-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[[(4E,8E,12E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxydocosa-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoyl]amino]octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[3-hydroxy-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoyl]amino]decoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[3-hydroxy-2-[[(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-13,16,19,22,25,28,31,34,37-nonaenoyl]amino]octoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-16,19,22,25,28,31-hexaenoyl]amino]tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C53H92N2O6P+ (883.6693)

Phophatidylethanolamine(22:1/24:1)

C51H98NO8P (883.703)

PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))

C52H86NO8P (883.6091)

PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))

C52H86NO8P (883.6091)

phosphatidylethanolamine 46:2

C51H98NO8P (883.703)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 46 carbons in total with 2 double bonds.

MePC(42:2)

C51H98NO8P (883.703)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

ST(43:4)

C49H89NO10S (883.6207)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 42:8;O2

C52H85NO10 (883.6173)

DGCC 43:7;O

C53H89NO9 (883.6537)

DGCC 44:6

C54H93NO8 (883.6901)

DGTS 43:7;O2

C53H89NO9 (883.6537)

DGTS 44:6;O

C54H93NO8 (883.6901)

DGTS 46:12

C56H85NO7 (883.6326)

PC 22:0/20:3;O

C50H94NO9P (883.6666)

PC 22:1/20:2;O

C50H94NO9P (883.6666)

PC 42:3;O

C50H94NO9P (883.6666)

PC 17:0_26:2

C51H98NO8P (883.703)

PC 17:1_26:1

C51H98NO8P (883.703)

PC 17:2_26:0

C51H98NO8P (883.703)

PC 18:2_25:0

C51H98NO8P (883.703)

PC 20:2_23:0

C51H98NO8P (883.703)

PC 20:5_24:4

C52H86NO8P (883.6091)

PC 21:0_22:2

C51H98NO8P (883.703)

PC 22:4_22:5

C52H86NO8P (883.6091)

PC 44:9

C52H86NO8P (883.6091)

LNAPE 45:3;O

C50H94NO9P (883.6666)

LNAPE 46:2

C51H98NO8P (883.703)

LNAPE 47:9

C52H86NO8P (883.6091)

PE 17:2_29:0

C51H98NO8P (883.703)

PE 18:2_28:0

C51H98NO8P (883.703)

PE 20:0_26:2

C51H98NO8P (883.703)

PE 20:1_26:1

C51H98NO8P (883.703)

PE 20:2_26:0

C51H98NO8P (883.703)

PE 22:1_24:1

C51H98NO8P (883.703)

PE 22:2_24:0

C51H98NO8P (883.703)

PE 46:2

C51H98NO8P (883.703)

LNAPS 43:3

C49H90NO10P (883.6302)

PS O-18:1/26:2

C50H94NO9P (883.6666)

PS O-18:2/26:1

C50H94NO9P (883.6666)

PS O-20:2/24:1

C50H94NO9P (883.6666)

PS O-22:1/22:2

C50H94NO9P (883.6666)

PS O-22:2/22:1

C50H94NO9P (883.6666)

PS O-44:3

C50H94NO9P (883.6666)

PS P-18:0/26:2

C50H94NO9P (883.6666)

PS P-18:0/26:2 or PS O-18:1/26:2

C50H94NO9P (883.6666)

PS P-18:1/26:1

C50H94NO9P (883.6666)

PS P-18:1/26:1 or PS O-18:2/26:1

C50H94NO9P (883.6666)

PS P-20:1/24:1

C50H94NO9P (883.6666)

PS P-20:1/24:1 or PS O-20:2/24:1

C50H94NO9P (883.6666)

PS P-22:0/22:2

C50H94NO9P (883.6666)

PS P-22:0/22:2 or PS O-22:1/22:2

C50H94NO9P (883.6666)

PS P-22:1/22:1

C50H94NO9P (883.6666)

PS P-22:1/22:1 or PS O-22:2/22:1

C50H94NO9P (883.6666)

PS P-44:2

C50H94NO9P (883.6666)

PS P-44:2 or PS O-44:3

C50H94NO9P (883.6666)

PS 17:1_26:2

C49H90NO10P (883.6302)

PS 17:2_26:1

C49H90NO10P (883.6302)

PS 18:3_25:0

C49H90NO10P (883.6302)

PS 20:3_23:0

C49H90NO10P (883.6302)

PS 43:3

C49H90NO10P (883.6302)

TDCAE 27:4

C53H89NO7S (883.6359)

TLCAE 28:3

C54H93NO6S (883.6723)